{"organizations": [], "uuid": "ce783185445ccebbdfb161063c78dbb2827dd803", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180201.html", "section_title": "Archive News &amp; Video for Thursday, 01 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-amgen-inc-q4-loss-per-share-589/brief-amgen-inc-q4-loss-per-share-5-89-idUSB8N19C050", "country": "US", "domain_rank": 408, "title": "BRIEF-Amgen Inc Q4 Loss Per Share $5.89", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-02T05:13:00.000+02:00", "replies_count": 0, "uuid": "ce783185445ccebbdfb161063c78dbb2827dd803"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-amgen-inc-q4-loss-per-share-589/brief-amgen-inc-q4-loss-per-share-5-89-idUSB8N19C050", "ord_in_thread": 0, "title": "BRIEF-Amgen Inc Q4 Loss Per Share $5.89", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "amgen inc", "sentiment": "negative"}, {"name": "brief-amgen inc", "sentiment": "negative"}, {"name": "amgen", "sentiment": "negative"}, {"name": "amgen ventures", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 1 (Reuters) - Amgen Inc:\n* AMGEN QTRLY LOSS PER SHARE $5.89; QTRLY ADJUSTED EARNINGS PER SHARE $2.89; QTRLY REVENUE $5.80 BILLION, DOWN 3 PERCENT\n* AMGEN - QTRLY LOSS PER SHARE INCLUDES $6.1 BILLION CHARGE RELATED TO IMPACT OF U.S. TAX REFORM\n* AMGEN SEES 2018 TOTAL REVENUE $21.8 BILLION - $22.8 BILLION; SEES 2018 EARNINGS PER SHARE $11.18 - $12.36; SEES 2018 ADJUSTED EARNINGS PER SHARE $12.60 - $13.70\n* AMGEN SEES 2018 CAPITAL EXPENDITURES TO BE ABOUT $750 MILLION\n* AMGEN - ADDITIONAL $10 BILLION OF SHARE REPURCHASES AUTHORIZED\n* AMGEN - NEW INVESTMENT PLAN INCLUDES COMMITTING UP TO $300 MILLION TO BUILD NEW MANUFACTURING PLANT IN THE U.S.\n* AMGEN - EXPECTS TO INVEST ABOUT $3.5 BILLION IN CAPITAL EXPENDITURES OVER NEXT 5 YRS, WITH ABOUT 75 PERCENT OF INVESTMENT IN THE U.S.\n* AMGEN - EXPECTS TO FINALIZE EXACT LOCATION OF NEW MANUFACTURING PLANT IN Q2\n* AMGEN - INCREASING SIZE OF AMGEN VENTURES FUND, PROVIDING UP TO $300 MILLION GROWTH CAPITAL FOR EARLY STAGE, BIOTECH COS IN THE U.S. Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-02T05:13:00.000+02:00", "crawled": "2018-02-02T12:35:28.024+02:00", "highlightTitle": ""}